Parkman Healthcare Partners LLC Vericel Corp Transaction History

Parkman Healthcare Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $715,968 - $1.07 Million	-20,340 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $4.23 Million - $6.08 Million	-89,660 Reduced 81.51%	20,340 $1.07 Million
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $8.99 Million - $17.3 Million	-290,743 Reduced 72.55%	110,000 $6.11 Million
Q4 2020 Feb 12, 2021	SELL	$18.53 - $31.5 $920,144 - $1.56 Million	-49,657 Reduced 11.03%	400,743 $12.4 Million
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $365,473 - $476,011	-24,896 Reduced 5.24%	450,400 $8.35 Million
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $1.23 Million - $2.29 Million	145,000 Added 43.9%	475,296 $6.57 Million
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $1.07 Million - $2.85 Million	-148,204 Reduced 30.97%	330,296 $3.03 Million
Q4 2019 Feb 13, 2020	BUY	$13.77 - $19.2 $6.59 Million - $9.19 Million	478,500 New	478,500 $8.33 Million

275

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.